Croall et al., 2015 - Google Patents
Magnetic resonance spectroscopy for traumatic brain injuryCroall et al., 2015
- Document ID
- 5779086363585290180
- Author
- Croall I
- Smith F
- Blamire A
- Publication year
- Publication venue
- Topics in Magnetic Resonance Imaging
External Links
Snippet
Magnetic resonance spectroscopy (MRS) provides a noninvasive tool to assess metabolic change in the brain following head injury. Observable metabolites reflect neuronal density and viability, glial density, membrane injury, and hypoxia or ischemia. MRS has been used …
- 206010070976 Craniocerebral injury 0 title abstract description 44
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
- G01R33/56341—Diffusion imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4806—Functional imaging of brain activation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Croall et al. | Magnetic resonance spectroscopy for traumatic brain injury | |
MacDonald et al. | MRI of healthy brain aging: A review | |
Goh et al. | Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging | |
Govindaraju et al. | Volumetric proton spectroscopic imaging of mild traumatic brain injury | |
Prescot et al. | Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study | |
Wang et al. | Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease | |
Warren et al. | Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors | |
Wang et al. | Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression | |
Kalra | Magnetic resonance spectroscopy in ALS | |
Baeshen et al. | Test–retest reliability of the brain metabolites GABA and Glx with JPRESS, PRESS, and MEGA‐PRESS MRS sequences in vivo at 3T | |
Eylers et al. | Detection of normal aging effects on human brain metabolite concentrations and microstructure with whole-brain MR spectroscopic imaging and quantitative MR imaging | |
Lin et al. | Metabolic changes in acute cerebral infarction: Findings from proton magnetic resonance spectroscopic imaging | |
Gasparovic et al. | 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment | |
Caverzasi et al. | Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature | |
Marino et al. | 1 H-MR spectroscopy in traumatic brain injury | |
Hardan et al. | A proton spectroscopy study of white matter in children with autism | |
Zahr et al. | A mechanism of rapidly reversible cerebral ventricular enlargement independent of tissue atrophy | |
Gröger et al. | Differentiation between idiopathic and atypical parkinsonian syndromes using three-dimensional magnetic resonance spectroscopic imaging | |
Hnilicová et al. | Spatial variability and reproducibility of GABA‐edited MEGA‐LASER 3D‐MRSI in the brain at 3 T | |
Kirov et al. | Longitudinal inter‐and intra‐individual human brain metabolic quantification over 3 years with proton MR spectroscopy at 3 T | |
de Seze et al. | Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica | |
Sneider et al. | A review of magnetic resonance spectroscopy studies in marijuana using adolescents and adults | |
Wiebenga et al. | Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging | |
Saleh et al. | Reproducibility of macromolecule suppressed GABA measurement using motion and shim navigated MEGA-SPECIAL with LCModel, jMRUI and GANNET | |
Inglese et al. | Quantitative MRI: hidden age-related changes in brain tissue |